Bariatric Surgery May Improve Outcomes for Obese Patients with Inflammatory Bowel Disease
New research reveals that bariatric surgery can significantly improve inflammatory bowel disease outcomes in obese patients, offering a promising integrated treatment approach.
Recent research suggests that bariatric surgery could play a beneficial role in managing inflammatory bowel disease (IBD) among patients with obesity. A comprehensive study published online on July 22 in BJS Open examined the impact of surgical weight loss procedures on IBD outcomes. The study was led by Dr. Erik Stenberg from Örebro University in Sweden and involved a nationwide cohort of adult Swedish patients with both obesity and IBD, spanning from 2007 to 2020.
The research included 798 patients, with half undergoing bariatric surgery—either sleeve gastrectomy or Roux-en-Y gastric bypass—and the other half serving as controls. Over the follow-up period, those who had surgery experienced significantly fewer events indicative of IBD worsening, such as hospitalizations, initiation of corticosteroids or immunomodulators, and major disease-related surgeries. Specifically, the primary composite endpoint occurred in 201 patients with surgery compared to 226 without, reflecting a hazard ratio of 0.66, which signifies a 34% reduction in risk.
Importantly, both types of bariatric procedures showed a trend toward reducing IBD complications, but the statistically significant results were primarily associated with Roux-en-Y gastric bypass. These findings indicate that bariatric surgery might be a useful intervention not only for weight loss but also for reducing the severity and progression of IBD in obese patients.
This research underscores the potential dual benefits of bariatric surgery for individuals suffering from obesity and IBD, illuminating new avenues for comprehensive treatment strategies. For more detailed information, refer to the original study in BJS Open at this link.
Source: https://medicalxpress.com/news/2025-08-bariatric-surgery-linked-ibd-outcomes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
P2Y12 Inhibitors Outperform Aspirin for Preventing Heart Attack and Stroke in Coronary Artery Disease Patients
A new study shows that P2Y12 inhibitors like clopidogrel and ticagrelor may be more effective than aspirin in preventing heart attacks and strokes in coronary artery disease patients, with similar safety profiles.
Nerve Cells Responsible for Pain Detection Could Offer New Strategies to Treat Lung Scarring
New research reveals pain-sensing nerve cells play a crucial role in protecting the lungs from scarring, opening potential new treatments for pulmonary fibrosis.
FDA Considers Easing Restrictions on Hormone Therapy for Menopause Symptoms
The FDA is reviewing potential changes to hormone therapy warnings for menopause symptoms, which could help reduce unnecessary fears and improve treatment options for women.
Revised Adult Sinusitis Guidelines Highlight Patient Education and Shared Decision-Making
The AAO-HNSF has published updated guidelines for adult sinusitis, emphasizing patient education, shared decision-making, and evidence-based management to improve outcomes and reduce unnecessary antibiotic use.